CLINICAL TRIALS PROFILE FOR DALTEPARIN SODIUM
✉ Email this page to a colleague
All Clinical Trials for dalteparin sodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00245856 ↗ | Treatment of Upper Extremity Deep-Vein Thrombosis | Completed | Pfizer | Phase 4 | 2002-09-01 | The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months. |
NCT00245856 ↗ | Treatment of Upper Extremity Deep-Vein Thrombosis | Completed | University of Oklahoma | Phase 4 | 2002-09-01 | The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months. |
NCT00264381 ↗ | Management of Superficial Thrombophlebitis | Completed | Pfizer | Phase 4 | 2002-10-01 | The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial thrombophlebitis (STP). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dalteparin sodium
Condition Name
Clinical Trial Locations for dalteparin sodium
Trials by Country
Clinical Trial Progress for dalteparin sodium
Clinical Trial Phase
Clinical Trial Sponsors for dalteparin sodium
Sponsor Name